Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
The Mangrove Partners Master Fund, Ltd. v. VirnetX Inc.
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
The Mangrove Partners Master Fund, Ltd.
Patent Owner:
VirnetX Inc.
Patent Number:
Tech Center:
2100
-
October 29, 2021
VirnetX Loses Bids For USPTO To Review Apple PTAB Rulings
The U.S. Patent and Trademark Office director has rejected requests to rehear inter partes review decisions invalidating VirnetX network security patents involved in the company's $576 million verdict against Apple.
-
July 15, 2020
Apple Nabs PTAB Win Against VirnetX, Seeks Remote Hearing
Apple on Tuesday asked the Eastern District of Texas to hold a pretrial conference for its upcoming $700 million retrial with VirnetX remotely amid a surge of COVID-19 cases, the same day the Patent Trial and Appeal Board struck down parts of two VirnetX patents involved in the companies' battle.
-
May 15, 2020
Apple Says VirnetX IPRs Were Wrongly Halted Under Arthrex
Apple and Mangrove Partners have told the Patent Trial and Appeal Board that their challenges to VirnetX patents shouldn't be held in abeyance until the Arthrex litigation is settled, since their cases have nothing to do with the contentious appointments clause case.
-
March 07, 2016
Apple Must Answer VirnetX On Patent Review, Fed Circ. Says
The Federal Circuit ordered Apple on Monday to respond to VirnetX's petition seeking to undo a Patent Trial and Appeal Board decision allowing the technology giant to join a hedge fund's inter partes review of some of the VirnetX patents at issue in its $625 million patent verdict against Apple and issued a stay on the review.
-
January 05, 2016
VirnetX Asks PTAB To Reconsider Hedge Fund Data Request
VirnetX on Monday asked the Patent Trial and Appeal Board to reconsider a decision that prevented it from seeking out more information about the relationship between a group challenging two of its network security patents and a Cayman Islands-based hedge fund.
-
October 07, 2015
Hedge Fund Gets PTAB To Eye VirnetX Patents In Apple Case
A hedge fund persuaded the Patent Trial and Appeal Board on Wednesday to review two VirnetX network security patents that Apple has been found to infringe, as the board rejected VirnetX's argument that the fund's petitions should be denied as an improper attempt to manipulate its stock price.